WILMINGTON, Mass., March 9, 2015 /PRNewswire/ -- Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, announced today that it has received notification that the bid protest filed with the Government Accountability Office (GAO) regarding the Company's recent 1,170 unit ETD award under Solicitation HSTS04-14-R-CT2050 has been denied. The stop work order has been lifted and the TSA order, initially issued on November 10, 2014, will ship according to TSA's delivery schedule.
"The GAO's decision validates TSA's original award of the Explosives Trace Detection contract to Implant Sciences. This marks Implant Sciences as the first small business to successfully introduce new ETD technology into aviation security and achieve approval through the TSA Qualified Products List process in over a decade," stated Dr. Bill McGann, President and CEO of Implant Sciences Corporation. "This award further establishes Implant Sciences as a leader in Explosives Trace Detection."
"We are pleased that the GAO has rendered its decision on the protest," stated Implant Sciences' Vice President of Global Sales and Marketing, Dr. Darryl Jones. "We will begin executing on this order and look forward to its fulfillment."
About Implant Sciences
Implant Sciences is a leader in developing and manufacturing advanced detection capabilities to counter and eliminate the ever-evolving threats from explosives and drugs. The Company's team of dedicated trace detection experts has developed proprietary technologies used in its commercial products, thousands of which have been sold across more than 50 countries worldwide. The Company's ETDs have received approvals and certifications from several international regulatory agencies including the TSA in the U.S., ECAC in Europe, STAC in France, the German Ministry of the Interior, and CAAC in China. It also received a GSN 2013 Homeland Security Award for "Best Explosives Detection Solution". All Implant Sciences products are recognized as Qualified Anti-Terrorism Technologies by the Department of Homeland Security. For further details on the Company and its products, please visit the Company's website at www.implantsciences.com.
Safe Harbor Statement
This press release may contain certain "forward-looking statements," as that term is defined in the Private Securities Litigation Reform Act of 1995. Such statements are based on management's current expectations and are subject to risks and uncertainties that could cause the Company's actual results to differ materially from the forward-looking statements. Such risks and uncertainties include, but are not limited to: the risk that there is no guaranty that U.S. or foreign government and law enforcement agencies or commercial consumers will purchase any of our products or that any new products we may develop will be accepted by the TSA or by such other governments, agencies or consumers; economic, political and other risks associated with international sales and operations could adversely affect our sales; our business is subject to intense competition and rapid technological change, and our success will depend on our ability to develop and introduce new products; and other risks and uncertainties described in our filings with the Securities and Exchange Commission, including our most recent Forms 10-K, 10-Q and 8-K. Such statements are based on management's current expectations and assumptions which could differ materially from the forward-looking statements.
Implant Sciences Corporation
Mike Turmelle, Director
978-752-1700 x 116
SOURCE Implant Sciences Corporation